Publications 1. Therapeutic potential of oncolytic Newcastle disease virus – a critical review. Tayeb S., Zakay-Rones Z. Panet A. Oncolytic virotherapy, 2015;4:49-62. 2. The oncolytic activity of Newcastle disease virus NDV-HUJ on chemoresistant primary melanoma cells is dependent on the proapoptotic activity of the inhibitor of apoptosis protein Livin. Lazar I, Yaacov B, Shiloach T, Eliahoo E, Kadouri L, Lotem M, Perlman R, Zakay-Rones Z, Panet A, Ben-Yehuda D.J Virol. J Virol. 2010 Jan;84(1):639-46. 3. Selective oncolytic effect of an attenuated Newcastle disease virus (NDV-HUJ) in lung tumors.Yaacov B, Eliahoo E, Lazar I, Ben-Shlomo M, Greenbaum I, Panet A, Zakay-Rones Z. Cancer Gene Ther. 2008 Dec;15(12):795-807. 4. Phase I/II trial of intravenous NDV-HUJ oncolytic virus in recurrent glioblastoma multiforme.Freeman AI1, Zakay-Rones Z, Gomori JM, Linetsky E, Rasooly L, Greenbaum E, Rozenman-Yair S, Panet A, Libson E, Irving CS, Galun E, Siegal T. Molecular Therapy 2006;13(1): 221-228.
